Psychopharmacology and Psychiatry Updates

A podcast by Psychopharmacology Institute

Categorie:

265 Episodio

  1. Naltrexone in Youth: Exploring Potential Applications and Cautions

    Pubblicato: 12/04/2023
  2. Lamotrigine Titration: Slowing Down for Safer Treatment

    Pubblicato: 07/04/2023
  3. Using Benzodiazepines in Geriatric Patients

    Pubblicato: 02/04/2023
  4. Lithium Use in Pediatric Patients

    Pubblicato: 28/03/2023
  5. Using Mood Stabilizers in the Geriatric Population

    Pubblicato: 23/03/2023
  6. Bright Light Therapy for Perinatal Depression

    Pubblicato: 18/03/2023
  7. Using SSRIs in the Geriatric Population

    Pubblicato: 13/03/2023
  8. Safety and Efficacy of Duloxetine in Youth With MDD

    Pubblicato: 08/03/2023
  9. Challenges in Prescribing Psychotropics to the Geriatric Population

    Pubblicato: 03/03/2023
  10. Antidepressants and Vertebral and Hip Risk Fractures

    Pubblicato: 26/02/2023
  11. Antidepressants and Mood Stabilizers for Managing Explosive Behavior

    Pubblicato: 21/02/2023
  12. Risk of Substance Use Disorders in Children Treated With Psychotropics

    Pubblicato: 16/02/2023
  13. FGAs and SGAs for Managing Explosive Behavior

    Pubblicato: 11/02/2023
  14. Use of Metformin to Prevent Clozapine-Induced Weight Gain

    Pubblicato: 06/02/2023
  15. Managing Acute Aggression in Children and Adolescents

    Pubblicato: 01/02/2023
  16. Early Antipsychotic Nonresponse as a Predictor of Nonresponse

    Pubblicato: 27/01/2023
  17. Differential Diagnosis of Explosive Behavior

    Pubblicato: 22/01/2023
  18. Long-Term Follow-Up of Schizophrenia in Youth

    Pubblicato: 17/01/2023
  19. The Serotonin Theory of Depression

    Pubblicato: 12/01/2023
  20. SSRIs and Type 2 Diabetes in Children and Adolescents

    Pubblicato: 07/01/2023

8 / 14

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Visit the podcast's native language site